CV
CVBenjamin Tseng
Product executive, Deeptech + AI technologist
Professional Experience
Syncretic Labs
2023 – Present • RemoteProduct / Strategy / AI
Syncretic Labs is a bespoke advisory and technology practice partnering with venture-backed deeptech, defense, and AI companies.
- Secured $1M+ (with path to $40M) Government Funding: Authored edge-AI architecture and technical plan for a defensetech solicitation, resulting in a $1M initial award with a $40M+ milestone pathway.
- Fundraising Narrative for $35M Series A: Built data room, consolidated financials (from scratch), and strategic narrative to support a $35M fundraise for a deeptech company navigating government contracting.
- Predictive Models for Material Properties: Engineered Deep Learning & ML models (PyTorch & Scikit-learn) for a materials startup to predict physical properties of products, shaping sampling and monitoring.
- Infrastructure for Global Creator Agency Operations: Led product management and software architecture for a creator agency reaching millions of fans; built internal metrics, engagement tools, and growth infrastructure.
- Reinforcement Learning Thought Leadership: Authored strategic whitepaper on applying RL to model defense strategy in the Pacific theater.
- AI-Powered Operational Efficiency: Designed & shipped AI-powered automation tool to streamline experiment follow-ups for a deeptech startup, increasing accuracy and cutting scheduling time
- Market Strategy & Revenue Diversification: Profiled non-defense revenue streams for defensetech startup to align firm capabilities with market opportunity
- Technical Team Leadership: Managed a 13-person team of data scientists and software engineers, balancing agile product discovery and core technology development with oversight of an AI product portfolio.
- Technical Due Diligence: Evaluated spectroscopic technology, data pipeline/ML architecture, and industry technology evolution as part of M&A due diligence for a leading circular economy company.
Stir
2021 – 2023 • San Francisco, CAHead of Product
Stir was a venture-backed company focused on building technology to enable creatives to better collaborate which raised $20M from top Silicon Valley VCs such as Homebrew and a16z
- Guided roadmap and implementation of product functionality (including key features such as Manager Access, mobile web, Invoices, international payments, early monetization, etc.) which helped grow transaction volume from <$2M/yr to >$200M/yr at its peak.
- Strong experience working with Plaid and Stripe APIs to deliver customized financial service offerings.
- Built metrics and reporting infrastructure from the ground-up with a mix of SQL and business intelligence tooling for internal purposes and to support reporting needs of multiple enterprise customers
- Served as data science/AI lead, building Playwright & BeautifulSoup-based scrapers, a prototype prompt engineering tool for image generation, serverless vector-based image search functionality, and a prototype chained LLM metasearch application.
Maximus
2020 – 2021 • remoteVP Product
Maximus is a consumer health company that provides men with content, community, and clinical support to optimize them in mind and body. Maximus raised $15M from top Silicon Valley VCs such as Founders Fund and 8VC as well as leading angel investors/operators
- Provided product and operational leadership culminating in release of MVP version of company’s first subscription product offering in Q2 2021.
- Oversaw team of engineers & designers supporting all software product and internal systems development within company.
- Developed user-friendly patient experience and compliant legal & software infrastructure needed for multi-state telemedicince operations in coordination with regulatory, finance, pharmacy partners, clinical labs partners, electronic medical record, clinicians, and other third parties
- Built “operator manual” for launch operations that can be handed over to non-technical staff
- Guided roadmap for further state and product launches, user experience enhancements, and infrastructure / operational improvements
- Continue to serve as an advisor
Clint Health
2019 – 2020 • Palo Alto, CAProduct Consultant
Clint, the clinical intelligence platform, automates the identification of a patient’s true clinical state by analyzing all medical data the same way a physician does. Clint understands what conditions a patient has, why they have it, how well they have been treated, and how they should be treated. Armed with these clinical grade insights, clinicians and researchers are able to identify and treat guideline directed care gaps, identify patients eligible for clinical trials and unite clinical care with clinical research.
- Provided product management, design & engineering leadership, and strategic guidance for several of company’s product efforts
- Overhauled prior dashboard product to improve usability and support insight needs for commercial / medical affairs customers within life sciences organizations
- Developed care gap closure use case for payer / value-based provider customers and built framework for opportunity sizing to facilitate pitches
- Built initial concept prototypes on clinical trial optimization / external control arm product
1955 Capital
2016 – 2019 • Bay Area, CAPrincipal (Deeptech / Cross-Border VC); later Venture Partner
1955 Capital is a U.S.-based venture capital firm that invests in technologies from the developed world that can help solve the developing world’s greatest challenges in areas like energy, the environment, food safety, health, education, and manufacturing.
- Team member #1 with far-ranging responsibilities including sourcing, due diligence, fundraising, deal execution, team construction, and process creation
- Generalist within the firm with emphasis across deep technologies (cleantech, semiconductors, hardware, and healthcare)
- Worked directly with portfolio company management teams including Gridtential, Nature’s Fynd, Ampaire, Craif, and Vital Bio, and other still-unannounced investments in aviation, energy, diagnostics, and advanced materials
- Created firm’s first special purpose vehicles for investments leveraging alternative capital formation as strategy
Yik Yak
2015 – 2017 • Atlanta, GAVP Product & Business Development
Yik Yak was a venture-backed startup building hyperlocal communities for mobile devices which has raised over $70M in venture funding since its inception.
- Drove Series B fundraising process leading to a $60M+ financing
- Built and managed team of 6 PMs, designers, and UX researchers supporting all product and systems development within company
- Guided roadmap and implementation of over 1 year of releases (including key functionality like phone number verification, reply icons, notification center, My Herd, sharing, web)
- Handled all preliminary partnership conversations and executed on partnerships with University of Florida, MTV, Comedy Central, and Bleacher Report
DCM
2010 – 2015 • Menlo Park, CAVice President (Global Early-Stage VC)
DCM is an early-stage global venture capital firm managing over $4B across Silicon Valley, Beijing, and Tokyo.
- Generalist within firm with emphasis on opportunities in deep technologies (cleantech, semiconductors), connected platforms (MVNO, smart TV, OTT streaming), and new models for healthcare
- Drove due diligence processes on and worked directly with management at portfolio companies on product strategy, fundraising, financial planning, business development and hiring including SoFi, Whistle, 1Mainstream, Analogix, Matterport, PlayStudios, Cognitive Networks, and Enovix
- Built software tool to programmatically parse data from AppAnnie (mobile app store rankings data vendor)
Bain & Company
2007 – 2010 • Bay Area, CASenior Associate Consultant
Bain & Company is a leading global management consulting firm.
- Performed competitive benchmarking to compare a client’s manufacturing operations with industry best-in-class.
- Analyzed technology industry profitability to identify attractive growth vectors for large tech client and highlight key differences between profit/power concentration in different verticals.
- Conducted financial and strategic diligence on wide range of potential acquisition targets (ranging in value from ~$100M to over $50B) to map out strategic acquisition options and gameboarding scenarios for a Fortune 500 technology client.
- Facilitated concept development and pilot phase of client initiative to provide operational support services for supply chain.
- Provided strategic and financial analysis to aid multiple clients in determining appropriate response to potentially disruptive trends; topics covered include cloud computing, mobile commerce, next-generation semiconductor manufacturing, cross-border eCommerce, social networking, etc.
- Devised presentation for CEO-level conversation on a process to pro-actively acquire/partner with assets which can aid client in dealing with disruptive innovations.
- Overhauled Bain toolkit for codification in book by Bain partners Mark Gottfredson and Steve Schaubert, The Breakthrough Imperative.
Roche Pharmaceuticals
2005 • Palo Alto, CAResearch Intern, Drug Metabolism & Pharmacokinetics
Roche Pharmaceuticals is a leading global pharmaceutical healthcare company.
- Validated use of Isothermal Titration Calorimeter in enzyme kinetics studies.
- Assessed factors limiting application of approach to study of Cytochrome P450 enzyme system.
- Presented findings at department seminar.
Abgenix Corporation
2003 • Fremont, CAIntern, Process Sciences
Abgenix was a biotechnology pioneer developing humanized antibody therapeutics (acquired by Amgen in 2006).
- Performed optimization studies for ELISA protocols used by Abgenix’s Process Sciences division.
- Presented findings at department seminar.
Education
Harvard University
2003 – 2007 • Cambridge, MAA.B. Magna Cum Laude with Highest Honors in Biochemical Sciences • Secondary Field in Mathematical Sciences
- Academic Honors: Phi Beta Kappa, Dean’s Research Award (2006), Harvard College Research Program Award (2006), Harvard College Scholar (2005–2006), Tylenol Scholar (2005–2006).
- Honors Thesis: “Transcriptional Regulation of Members of the Tripartite Motif Family in Response to Viral Infection” (Dept. of Molecular & Cellular Biology).
- Activities & Leadership: Operations Director, Harvard College Asian Business Forum (2005–2006); Associate Editor & Writer, Next Generation MD (2005–2007); Media Department Head (2004–2005) & Visuals Editor (2003–2004), Harvard International Review.
Advisory & Consultancies
Whistle
Acquired by MarsAdvisory on connected IoT hardware, canine telemetry analytics, and acquisition strategy.
Dextro
Acquired by AxonComputer vision infrastructure for real-time video stream analysis and public safety surveillance.
Companion Labs
Raised $14M VCAutonomous computer vision and reinforcement learning hardware for pet behavioral training.
310.ai
Generative BiologyGenerative foundation models for computational protein and enzyme molecular design.
Rosie.ai
AI Agent ToolsAgentic spreadsheet automation and financial modeling co-pilots for operators.
Extend
Raised $17M VCEnterprise AI document extraction and intelligent workflow automation.
Swarm Aero
Raised $59M in VCAutonomous unmanned aerial systems and decentralized swarm architecture for defense.
Fortera
Raised $100M+ VCLow-carbon green cement chemistry and industrial decarbonization plant scale-up.
Academic Research & Publications
Stanford Ophthalmic Informatics & AI Group (OPTIMA)
2019 – Present • Stanford, CAStanford University Byers Eye Institute • Collaborator with Prof. Sophia Y. Wang
Applying deep learning and natural language processing to electronic health records (EHRs) to predict clinical progression and visual prognosis.
- Ophthalmology Science (2022): “Deep Learning Approaches for Predicting Glaucoma Progression Using Electronic Health Records and Natural Language Processing” [Paper] [PDF]
- International Journal of Medical Informatics (2022): “Looking for low vision: Predicting visual prognosis by fusing structured and free-text data from electronic health records” [PMC] [DOI] [PDF]
- International Journal of Medical Informatics (2021): “Development and evaluation of novel ophthalmology domain-specific neural word embeddings to predict visual prognosis” [DOI] [PDF]
- American Glaucoma Society (2021): “Predicting Glaucoma Progression and Surgical Intervention from Clinical Notes” [Summary] [Poster PDF]
- Learning Health Systems / MCBK (2020): Clinical Low Vision Prediction from Multimodal EHRs [Poster PDF]
- Deep Learning Model: Using AI to Predict if an Ophthalmology Paper will be in a Top-Tier Journal [Summary & Code]
Maniatis Group
2004 – 2007 • Cambridge, MAHarvard University • Dept. of Molecular & Cellular Biology • Prof. Tom Maniatis
Completed senior honors thesis “Transcriptional Regulation of Members of the Tripartite Motif Family” examining retroviral restriction factor gene regulation in response to viral infection and interferon signaling.
Brenner Group
2006 – 2007 • Cambridge, MAHarvard University • Division of Engineering & Applied Sciences • Prof. Michael P. Brenner
Applied separation of timescales and dominant balances towards simplifying complex biological systems, analyzing mathematical constraints governing steady-state Ran GTPase concentration gradients across nuclear pores.
Brown Group
Summer 2004 • Stanford, CAStanford Medical School • Center for Clinical Science Research • Prof. Janice (Wes) M. Y. Brown
Researched stem cell reconstitution of murine immune systems in conjunction with antifungal agents and combinations of lymphoid and myeloid progenitor cells. Research summarized in: Arber C, et al. Journal of Infectious Diseases (2005).